Towards a clinical use of miRNAs in pancreatic cancer biopsies

Expert Review of Molecular Diagnostics

Volumn 13, Issue 1, 2013, Pages 31-34

  Frampton, Adam E ^a   Gall, Tamara Mh ^a   Castellano, Leandro ^b   Stebbing, Justin ^c   Jiao, Long R ^a   Krell, Jonathan ^b  

^a Hammersmith Hospital Campus   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c Hammersmith Hospital Campus   (United Kingdom)

Author keywords

biomarker; diagnostic; endoscopic ultrasound; fine needle aspirate; let 7; miR 200c; miR 451; miRNA; pancreatic ductal adenocarcinoma

Indexed keywords

MICRORNA; MICRORNA 21; TUMOR MARKER;

CANCER RESISTANCE; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREAS DISEASE; REVIEW; SOLID TUMOR; TISSUE SPECIFICITY; TUMOR BIOPSY;

EID: 84871535770     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.136     Document Type: Review

References (21)

1. Ali S, Saleh H, Sethi S, Sarkar FH, Philip PA. MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br. J. Cancer 107(8), 1354-1360 (2012).
2. Jiao LR, Frampton AE, Jacob J et al. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS ONE 7(2), e32068 (2012).
3. Olive V, Jiang I, He L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 42(8), 1348-1354 (2010).
4. Shigoka M, Tsuchida A, Matsudo T et al. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol. Int. 60(5), 351-357 (2010).
5. Wu CW, Ng SS, Dong YJ et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 61(5), 739-745 (2012).
6. Lee EJ, Gusev Y, Jiang J et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120(5), 1046-1054 (2007).
7. Hewitt MJ, McPhail MJ, Possamai L, Dhar A, Vlavianos P, Monahan KJ. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest. Endosc. 75(2), 319-331 (2012).
8. Xu K, Zhou L, Liang B et al. Safety and accuracy of percutaneous core needle biopsy in examining pancreatic neoplasms. Pancreas 41(4), 649-651 (2012).
9. Panarelli NC, Chen YT, Zhou XK, Kitabayashi N, Yantiss RK. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma. Pancreas 41(5), 685-690 (2012).
10. Munding JB, Adai AT, Maghnouj A et al. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int. J. Cancer 131(2), 86-95 (2012).
11. Szafranska AE, Doleshal M, Edmunds HS et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin. Chem. 54(10), 1716-1724 (2008).
12. Preis M, Gardner TB, Gordon SR et al. MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin. Cancer Res. 17(17), 5812-5821 (2011).
13. Hanoun N, Delpu Y, Suriawinata AA et al. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin. Chem. 56(7), 1107-1118 (2010).
14. Torrisani J, Bournet B, du Rieu MC et al. let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum. Gene Ther. 20(8), 831-844 (2009).
15. Sadakari Y, Ohtsuka T, Ohuchida K et al. MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma. JOP 11(6), 587-592 (2010).
16. Matthaei H, Wylie D, Lloyd MB et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin. Cancer Res. 18(17), 4713-4724 (2012).
17. Ryu JK, Matthaei H, Dal Molin M et al. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology 11(3), 343-350 (2011).
18. Habbe N, Koorstra JB, Mendell JT et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol. Ther. 8(4), 340-346 (2009).
19. Frampton AE, Krell J, Jacob J, Stebbing J, Jiao LR, Castellano L. microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma. Expert Rev. Anticancer Ther. 11(12), 1837-1842 (2011).
20. Frampton AE, Krell J, Zhang Y, Stebbing J, Castellano L, Jiao LR. The role of miR-10b in metastatic pancreatic ductal adenocarcinoma. Surgery 152(5), 936-938 (2012).
21. Frampton AE, Pai M, Krell J, Vlavianos P, Jiao LR, Spalding DR. The 'malignant truth' about the recurrence of pancreatic intraductal papillary mucinous neoplasms. Arch. Surg. 147(10), 977-980 (2012).